Artisan Small Cap Advisor (APDSX)
33.07
-0.71 (-2.10%)
USD |
Feb 03 2023
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
1.06% | 1.868B | 0.32% | 33.64% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
-629.97M | -2.49% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The investment seeks maximum long-term capital growth. The fund’s investment team employs a fundamental investment process to construct a diversified portfolio of U.S. small-cap growth companies. It invests primarily in U.S. companies and, under normal circumstances, the fund invests no less than 80% of its net assets plus any borrowings for investment purposes at market value at the time of purchase in the common stocks of small companies. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | ARTSX |
Equity Style | Mid Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | US Equity |
Broad Category | Equity |
Category Name | Small Growth |
Category Index | Russell 2000 Growth TR USD |
Global Category Name | US Equity Small Cap |
YCharts Categorization | US Small Cap |
YCharts Benchmark | Russell 2000 Total Return (^RUTTR) |
Prospectus Objective | Small Company |
Fund Owner Firm Name | Artisan Partners Funds |
Prospectus Benchmark Index | |
Russell 2000 TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Manager Tenure | |
Craigh Cepukenas | 18.27 yrs |
James Hamel | 13.26 yrs |
Matthew Kamm | 12.97 yrs |
Jason White | 11.93 yrs |
Jay Warner | 0.98 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
93
-629.97M
-1.604B
Category Low
752.72M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2022
Performance Versus Category
As of February 03, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of February 03, 2023.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Halozyme Therapeutics Inc | 9.86% | 52.65 | -0.42% |
Lattice Semiconductor Corp | 6.45% | 79.53 | -2.96% |
Valmont Industries Inc
|
5.28% | -- | -- |
argenx SE ADR | 5.17% | 370.95 | -0.35% |
Ascendis Pharma A/S ADR | 4.64% | 116.10 | -1.39% |
ShockWave Medical Inc | 4.23% | 187.32 | -1.15% |
BlackLine Inc | 3.53% | 76.00 | -2.06% |
Monolithic Power Systems Inc | 3.37% | 456.30 | -3.73% |
Novanta Inc | 3.04% | 167.37 | -1.88% |
Wingstop Inc | 2.88% | 165.96 | 0.22% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | -- |
Actual Management Fee | Upgrade |
Administration Fee | -- |
Performance Fee | -- |
Switching Fee | -- |
Transaction Fee | -- |
Maximum Front Load | -- |
Maximum Deferred Load | -- |
Maximum Redemption Fee | -- |
Basic Info
Investment Strategy | |
The investment seeks maximum long-term capital growth. The fund’s investment team employs a fundamental investment process to construct a diversified portfolio of U.S. small-cap growth companies. It invests primarily in U.S. companies and, under normal circumstances, the fund invests no less than 80% of its net assets plus any borrowings for investment purposes at market value at the time of purchase in the common stocks of small companies. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | ARTSX |
Equity Style | Mid Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | US Equity |
Broad Category | Equity |
Category Name | Small Growth |
Category Index | Russell 2000 Growth TR USD |
Global Category Name | US Equity Small Cap |
YCharts Categorization | US Small Cap |
YCharts Benchmark | Russell 2000 Total Return (^RUTTR) |
Prospectus Objective | Small Company |
Fund Owner Firm Name | Artisan Partners Funds |
Prospectus Benchmark Index | |
Russell 2000 TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Manager Tenure | |
Craigh Cepukenas | 18.27 yrs |
James Hamel | 13.26 yrs |
Matthew Kamm | 12.97 yrs |
Jason White | 11.93 yrs |
Jay Warner | 0.98 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (2-3-23) | 0.32% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 27.00 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of December 31, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 2/1/2017 |
Last Annual Report Date | 9/30/2022 |
Last Prospectus Date | 11/7/2022 |
Share Classes | |
APHSX | Inst |
ARTSX | Inv |
Attributes | |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |